Adial Pharmaceuticals Inc (NASDAQ:ADIL) does about 8.42M shares in volume on a normal day but saw 2713502 shares change hands in the recent trading day. The company now has a market cap of 8.00M USD. Its current market price is $0.51, marking an increase of 12.37% compared to the previous close of $0.45. The 52 week high reached by this stock is $3.00 whilst the lowest price level in 52 weeks is $0.22.
Adial Pharmaceuticals Inc (ADIL) has a 20-day trading average at $0.3563 and the current price is -83.10% off the 52-week high compared with 130.45% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.4911 and its 200-day simple moving average is $0.7944. If we look at the stock’s price movements over the week, volatility stands at 12.15%, which increases to 17.92% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 60.87 to suggest the stock is neutral.
The consensus objective for the share price is $2.00, suggesting that the stock has a potential upside of 74.5% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 14, 2024 when Rodman & Renshaw initiated the stock to “Buy” and issued a price target of $8.
The current price level is 42.29%, 3.25%, and -36.18% away from its SMA20, SMA50, and SMA200 respectively, with the ADIL price moving below the 50-day SMA on current market day. Adial Pharmaceuticals Inc (ADIL) stock is up 37.32% over the week and 112.13% over the past month. Its price is -52.62% year-to-date and -49.80% over the past year.
To reach the target analysts have set, the stock logically needs to grow 74.5 percent from here.
Outstanding shares total 15.78M with insiders holding 3.41% of the shares and institutional holders owning 3.64% of the company’s common stock. The company has a return on investment of -420.83% and return on equity of -217.01%. The beta has a value of 0.98. Price to book ratio is 1.59.
